Javara Research
PrivateLast Round
Series C
May 28, 2025
Total Funding Raised
$59.08M
Company Overview
Javara Research operates in Healthcare & Life Sciences and is based in Winston-Salem, North Carolina. Its latest recorded funding round was a Series C round in May 2025.
Javara Research is a healthcare and clinical research company that integrates clinical trials at the point of care by partnering with healthcare organizations to streamline the research experience.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, EHR & EMR, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Javara Research Comparables
Compare Javara Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Circuit Clinical | 89% | |
| Elligo Health Research | 88% | |
| Care Access | 85% |
For institutional investors. Book with your work email.
Javara Research Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 28, 2025 | ||||
| Debt | Nov 8, 2023 | ||||
| Series B | Apr 12, 2022 | ||||
| Series A Extension | Sep 1, 2021 | ||||
| Series A | Aug 14, 2020 | ||||
Series A | Aug 13, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Javara Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FCA Venture Partners | Series A |
| Dioko Ventures | Series A |
| General Atlantic | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors increased 80% MoM, reaching 15.6K.
- Jan 25, 2026
Partnered with Greater Gift to provide supplemental support.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardOct 22, 2026
Javara Inc. founder and CEO Jennifer Byrne is named the recipient of the 2026 Christine K. Pierre Site Impact Award by the Society for Clinical Research Sites during the 20th Anniversary Global Site Solutions Summit in Florida on Oct 22nd '26, recognizing her contributions to the clinical research site community.
For institutional investors. Book with your work email.
Javara Research Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Javara Research's valuation, stock price, and market status.
Is Javara Research a public or private company?
Javara Research is a private company.
What is the current stock price of Javara Research?
Javara Research is a private company, so its shares have no public market price. Caplight tracks Javara Research's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Javara Research worth (valuation)?
Valuation information for Javara Research is not publicly available.
Can I buy Javara Research stock?
Javara Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Javara Research's last funding round?
Javara Research's most recent funding round was Series C on May 28, 2025.
Who are the main investors in Javara Research?
Key investors in Javara Research include General Atlantic.
Will Javara Research IPO soon?
No public IPO plans have been announced for Javara Research.
How can I track Javara Research secondary market activity?
Caplight tracks bids, offers, and trades in Javara Research's shares on secondary markets.